KYIV, Ukraine & SANKT AUGUSTIN, Germany--(BUSINESS WIRE)--The two leading experts in the exploration of ultra-large make-on-demand chemical spaces join forces to spark a new era of drug discovery.
The MarketWatch News Department was not involved in the creation of this content. -- Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) ...
Enamine offers integrated drug discovery services empowered by its unique chemical tools – an unparalleled collection of modern compound libraries and building blocks. The company provides access to ...
Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organization (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the ...
Syntheticgestalt Ltd. and Enamine Ltd. have begun a joint effort to create a suite of artificial intelligence (AI) models that will enable the generation of synthetically accessible biologically ...
Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced ...
Pharmaceutical chemical provider Enamine has uploaded 43 million of its make-on-demand compounds to Elsevier’s Reaxys database. The compounds are synthetically feasible molecules derived from ...
Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated ...
Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results